Evidence map›Paper›PMID 41713836›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2026

Hemodialysis Facilities, Vascular Access Surgeons, and Central Venous Catheter Use: A Retrospective Cohort Study.

Kunal Bailoor, Mary K Oerline, Sunayna Gurnani, Paula Guro, Richard A Hirth, John M Hollingsworth, Vahakn B Shahinian

Abstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kunal BailoorDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: kbailoor@med.umich.edu.
Mary K OerlineDow Division of Health Services Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Sunayna GurnaniSouthwest Kidney Care, LLC, Albuquerque, NM.
Paula GuroDow Division of Health Services Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Richard A HirthDepartment of Internal Medicine, University of Michigan School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, Michigan.
John M HollingsworthDepartment of Urology, University of Florida College of Medicine, Gainesville, Florida.
Vahakn B ShahinianDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Funding

Leveraging the ESRD Treatment Choices model to understand the benefits of home versus in-center dialysisR01DK134406 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARD A HIRTH, John Malcolm Hollingsworth · 2023 to 2026
$2.6M
Training CoreTL1DK136046 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Laura H Mariani · 2022 to 2026
$2.5M
AHRQ HHS R01 HS026908NIDDK NIH HHS R01 DK134406NIDDK NIH HHS TL1 DK136046
6 · The paper itself

Abstract

RATIONALE &

objectiveReducing central venous catheter (CVC) use for hemodialysis among patients with kidney failure receiving maintenance hemodialysis is an important priority. Previous reports have suggested that partnerships between hemodialysis facilities and vascular access surgeons lead to reduced rates of CVC use. We studied whether a greater intensity of these relationships was associated with less use of CVCs. STUDY

designNational retrospective cohort study. SETTING &

participants109,293 patients with kidney failure receiving maintenance hemodialysis within 4,402 facilities. EXPOSURE: Facility-level Herfindahl-Hirschman index (HHI), an established measure of market concentration used as a proxy for closeness of the relationship between hemodialysis facilities and vascular access surgeons, with higher indices suggesting closer relationships. OUTCOME: Greater than 90 days of continuous CVC use for hemodialysis in 2018. ANALYTICAL APPROACH: Mixed-effects logistic regression model including patient-level covariates, facility-level covariates, and facility random effects. Dialysis facilities were divided into quartiles based on increasing HHI. Multiple sensitivity analyses were conducted using similar models.

resultsPatients in facilities in the highest HHI quartile were less likely to have continued catheter use for more than 90 days than those in the lowest quartile (odds ratio, 0.80; 95% confidence interval, 0.75-0.87; P < 0.001). This association was also observed in multiple sensitivity analyses. LIMITATIONS: Misclassification of the exposure, inclusion of patients insured by Medicare Fee-for-Service, unmeasured confounding.

conclusionsMore extensive partnerships between dialysis facilities and vascular access surgeons reflected by the HHI were associated with lower rates of CVC use for hemodialysis. PLAIN-LANGUAGE SUMMARY: The goal of this study was to learn if patients in dialysis facilities that partnered with surgeons (measured using a marker of market concentration) who place and maintain permanent hemodialysis vascular access grafts and fistulas experienced lower use of a temporary form of vascular access for hemodialysis, central venous catheters, which are associated with an increased risk of infection. We found that closer partnerships between hemodialysis centers and surgeons were associated with less use of catheters for the patients served by those dialysis centers. These findings may inform strategies to reduce the use of central venous catheters and improve outcomes for patients with kidney failure requiring dialysis.

Indexed as

Catheterization, Central VenousCentral Venous CathetersKidney Failure, ChronicRenal DialysisSurgeonsAgedCohort StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesUnited StatesCentral Venous CathetersHealth PolicyHemodialysis

Identifiers

PMID41713836
PMCPMC13094778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.